On August 1, 2025, VolitionRx Ltd entered a securities purchase agreement to issue 1.89 million shares of common stock at $0.64 each, raising $1.21 million for research and commercialization efforts. Additionally, insider directors received 156,250 shares but no warrants in this offering.